Cynthia Pussinen
Directeur Général chez SERNOVA CORP.
Fortune : - $ au 30/04/2024
Postes actifs de Cynthia Pussinen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SERNOVA CORP. | Directeur/Membre du Conseil | 05/09/2023 | - |
| Directeur Général | 05/09/2023 | - |
Historique de carrière de Cynthia Pussinen
Anciens postes connus de Cynthia Pussinen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SPARK THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2021 | 01/12/2022 |
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Formation de Cynthia Pussinen
| Rensselaer Polytechnic Institute | Graduate Degree |
| University of Connecticut | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SERNOVA CORP. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Bourse
- Insiders
- Cynthia Pussinen
- Expérience